A study by Asano et al. [34] showed that subcutaneously injected tumor cells can be transported to lymph nodes (LNs) through the lymphatic flow and were phagocytosed by CD169+ macrophages in the LN subcapsular sinus, which then directly cross-present the dead cell-associated antigens to CD8+T cells. Here, SIGLEC1 is linked to neoplasm.